Abstract
Borrelia afzelii is the predominant Borrelia species causing Lyme borreliosis in Europe. Currently there is no human vaccine against Lyme borreliosis, and most research focuses on recombinant protein vaccines against Borrelia burgdorferi sensu stricto. DNA tattooing is a novel vaccination method that can be applied in a rapid vaccination schedule. We vaccinated C3H/HeN mice with B. afzelii strain PKo OspC (outer-surface protein C) using a codon-optimized DNA vaccine tattoo and compared this with recombinant protein vaccination in a 0–2–4 week vaccination schedule. We also assessed protection by DNA tattoo in a 0–3–6 day schedule. DNA tattoo and recombinant OspC vaccination induced comparable total IgG responses, with a lower IgG1/IgG2a ratio after DNA tattoo. Two weeks after syringe-challenge with 5 × 105 B. afzelii spirochetes most vaccinated mice had negative B. afzelii tissue DNA loads and all were culture negative. Furthermore, DNA tattoo vaccination in a 0–3–6 day regimen also resulted in negative Borrelia loads and cultures after challenge. To conclude, DNA vaccination by tattoo was fully protective against B. afzelii challenge in mice in a rapid vaccination protocol, and induces a favorable humoral immunity compared to recombinant protein vaccination. Rapid DNA tattoo is a promising vaccination strategy against spirochetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stanek G, Reiter M . The expanding Lyme Borrelia complex—clinical significance of genomic species?. Clin Microbiol Infect 2011; 17: 487–493.
Stanek G, Wormser GP, Gray J, Strle F . Lyme borreliosis. Lancet 2012; 379: 461–473.
Radolf JD, Caimano MJ, Stevenson B, Hu LT . Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 2012; 10: 87–99.
Pal U, Yang X, Chen M, Bockenstedt LK, Anderson JF, Flavell RA et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 2004; 113: 220–230.
Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, Bueschel DM et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci USA 2004; 101: 3142–3147.
Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 2005; 436: 573–577.
Hovius JW, Schuijt TJ, de Groot KA, Roelofs JJ, Oei GA, Marquart JA et al. Preferential protection of Borrelia burgdorferi sensu stricto by a Salp15 homologue in Ixodes ricinus saliva. J Infect Dis 2008; 198: 1189–1197.
Poland GA . Vaccines against Lyme disease: what happened and what lessons can we learn?. Clin Infect Dis 2011; 52: s253–s258.
Schuijt TJ, Hovius JW, van der Poll T, van Dam AP, Fikrig E . Lyme borreliosis vaccination: the facts, the challenge, the future. Trends Parasitol 2011; 27: 40–47.
Luke CJ, Carner K, Liang X, Barbour AG . An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis 1997; 175: 91–97.
Scheiblhofer S, Weiss R, Durnberger H, Mostbock S, Breitenbach M, Livey I et al. A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses. Microbes Infect 2003; 5: 939–946.
Weiss R, Durnberger J, Mostbock S, Scheiblhofer S, Hartl A, Breitenbach M et al. Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine 1999; 18: 815–824.
Weiss R, Scheiblhofer S, Freund J, Ferreira F, Livey I, Thalhamer J . Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 2002; 20: 3148–3154.
Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TN et al. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 2005; 11: 899–904.
Zhong W, Gern L, Stehle T, Museteanu C, Kramer M, Wallich R et al. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur J Immunol 1999; 29: 946–957.
Zhong W, Stehle T, Museteanu C, Siebers A, Gern L, Kramer M et al. Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci USA 1997; 94: 12533–12538.
Dangl JL, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, Oi VT . Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 1988; 7: 1989–1994.
Earnhart CG, Marconi RT . Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens. Vaccine 2007; 25: 3419–3427.
Keane-Myers A, Nickell SP . Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995; 155: 2020–2028.
Matyniak JE, Reiner SL . T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 1995; 181: 1251–1254.
Zeidner N, Dreitz M, Belasco D, Fish D . Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma. J Infect Dis 1996; 173: 187–195.
Earnhart CG, Buckles EL, Dumler JS, Marconi RT . Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect Immun 2005; 73: 7869–7877.
Earnhart CG, Marconi RT . OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine. Clin Vaccine Immunol 2007; 14: 628–634.
Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ . Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 1999; 151: 15–30.
Probert WS, Crawford M, Cadiz RB, LeFebvre RB . Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J Infect Dis 1997; 175: 400–405.
Hovius JW . Spitting image: tick saliva assists the causative agent of Lyme disease in evading host skin's innate immune response. J Invest Dermatol 2009; 129: 2337–2339.
Bestor A, Rego RO, Tilly K, Rosa PA . Competitive advantage of Borrelia burgdorferi with outer surface protein BBA03 during tick-mediated infection of the mammalian host. Infect Immun 2012; 80: 3501–3511.
Ellis TC, Jain S, Linowski AK, Rike K, Bestor A, Rosa PA et al. In vivo expression technology identifies a novel virulence factor critical for Borrelia burgdorferi persistence in mice. PLoS Pathog 2013; 9: e1003567.
Gilmore RD Jr, Kappel KJ, Dolan MC, Burkot TR, Johnson BJ . Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect Immun 1996; 64: 2234–2239.
Mbow ML, Gilmore Jr RD, Titus RG . An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. Infect Immun 1999; 67: 5470–5472.
Gilmore Jr RD, Piesman J . Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice. Infect Immun 2000; 68: 411–414.
Verstrepen BE, Bins AD, Rollier CS, Mooij P, Koopman G, Sheppard NC et al. Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. Vaccine 2008; 26: 3346–3351.
Pokorna D, Rubio I, Muller M . DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther 2008; 6: 4.
Petersen TN, Brunak S, von Heijne G, Nielsen H . SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011; 8: 785–786.
Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 2005; 33: W526–W531.
Hovius JW, Li X, Ramamoorthi N, van Dam AP, Barthold SW, van der Poll T et al. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis. FEMS Immunol Med Microbiol 2007; 49: 224–234.
Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 2009; 37: e45.
Acknowledgements
We thank Erol Fikrig (Section of Infectious Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA) for providing the OspC-mutant Borrelia burgdorferi strain. This work was supported by a ‘Veni’ grant (91611065 and 91610095) received from The Netherlands Organisation for Health Research and Development (ZonMw).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Gene Therapy website
Supplementary information
Rights and permissions
About this article
Cite this article
Wagemakers, A., Mason, L., Oei, A. et al. Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection. Gene Ther 21, 1051–1057 (2014). https://doi.org/10.1038/gt.2014.87
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2014.87
This article is cited by
-
A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines
npj Vaccines (2022)
-
Probing an Ixodes ricinus salivary gland yeast surface display with tick-exposed human sera to identify novel candidates for an anti-tick vaccine
Scientific Reports (2021)
-
Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis
Scientific Reports (2021)
-
The role of Mannose Binding Lectin in the immune response against Borrelia burgdorferi sensu lato
Scientific Reports (2019)